Michael Weiser's Net Worth

$55 Million

Estimate Recalculated Sep 8, 2024 07:39PM EST

Who is Michael Weiser?

Michael Weiser has an estimated net worth of $55 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, SEWARD SCIENCES, INC., KANAI SCIENCES, INC., KODIAK SCIENCES, INC., Innovive Pharmaceuticals, Inc., Paramount Acquisition Corp, IOVANCE BIOTHERAPEUTICS, INC., MANHATTAN PHARMACEUTICALS INC, EMISPHERE TECHNOLOGIES INC, Hana Biosciences Inc, IVORY CAPITAL CORP, and CHIRAL QUEST INC.

SEC CIK

Michael Weiser's CIK is 0001221449

Past Insider Trading and Trends

2006 was Michael Weiser's most active year for acquiring shares with 21 total transactions. Michael Weiser's most active month to acquire stocks was the month of April. 2017 was Michael Weiser's most active year for disposing of shares, totalling 5 transactions. Michael Weiser's most active month to dispose stocks was the month of November. 2012 saw Michael Weiser paying a total of $139,774.38 for 93,112 shares, this is the most they've acquired in one year. In 2008 Michael Weiser cashed out on 13,921 shares for a total of $2,631,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83

Investor

Michael Weiser owns 135,945 units of Common Stock, $.001 par value which is worth $384,724.35 and 224,282 units of Common Stock which is worth $634,718.06.acquired a total of 332,757 shares in ZIOPHARM ONCOLOGY INC at a cost of $354,724.38, Michael also disposed a total of 108,475 shares of ZIOPHARM ONCOLOGY INC equalling to $606,521.89.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.27%
11.24K
$4.14
-$24,926.94
224.28K
Dec 29 - Dec 30
Form 4
+3.74%
7.67K
$3.58
$0.25
213.04K
Dec 8
Form 4
+0.83%
1.7K
$5.16
-$1.00
205.37K
Jun 12
Form 4
+4.02%
7.87K
$5.35
-$49,920.85
203.67K
Dec 30 - Dec 31
Form 4
+2.22%
4.25K
$6.95
-$20,318.88
195.8K
Apr 19
Form 4
+14.74%
24.61K
$8.31
-$17,010.57
191.55K
Dec 31
Form 4
-2.40%
-4.10K
$5.05
-$20,694.82
166.93K
Dec 30 - Dec 31
Form 4
-3.31%
-5.85K
$4.34
-$25,406.36
171.03K
Dec 31
Form 4
+9.70%
15.64K
$4.21
-$8,015.84
176.89K
Dec 31
Form 4
+5.03%
7.72K
$4.47
-$2.50
161.24K
May 31
Form 4
+12.93%
17.58K
—
—
153.52K
Dec 30
Form 4
-9.94%
-15.00K
$6.53
-$97,950.00
135.94K
May 25
Form 4
—
0
—
—
0
Dec 31
Form 4
+11.03%
15K
—
—
150.94K
Mar 31
Form 4
+5.84%
7.5K
—
—
135.94K
Dec 31
Form 4
+30.47%
30K
—
—
128.44K
Sep 23
Form 4
—
0
—
—
0
May 13
Form 4
+17.98%
15K
$0.83
$12,450.00
98.44K
Dec 3
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
Apr 26
Form 3
—
0
—
—
0
Form 4
∞
83.44K
—
—
83.44K
Sep 13
No matching records found

SEWARD SCIENCES, INC. No price found

President and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

KANAI SCIENCES, INC. No price found

President and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

KODIAK SCIENCES, INC. No price found

President and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Innovive Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 29
Form 3
—
0
—
—
0
No matching records found